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Results of irradiation-hyperthermia treatment in 11 dogs with naturally occurring 
hemangiopericytomas are reported. Similarities of canine and human hemangiopericytomas are 
described. Orthovoltage X-irradiation followed by microwave-induced hyperthermia resulted in 
a 91% objective response rate. A statistical procedure was given to evaluate quantitatively the 
clinical behavior of locally invasive, nonmetastatic tumors in dogs that were undergoing therapy 
for control of local disease. The procedure used a small sample size and demonstrated 
distribution of the data on a scaled response as well as transformation of the data through 
classical parametric and nonparametric statistical methods. These statistical methods set 
confidence limits on the population mean and placed tolerance limits on a population percentage. 
Application of the statistical methods to human and animal clinical trials is apparent. 
 
Key words. – cancer, carcinoma, clinical response, lymphoma, sarcoma, small sample size, 
statistical methods. 
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Canine hemangiopericytomas are excellent comparative models for human soft-tissue sarcomas. 
Their behaviors, histopathological appearances, blood supplies, and therapeutic responses are 
similar to those of human sarcomas (1-13). In dogs hemangiopericytomas are often bulky soft-
tissue sarcomas that are encountered on the extremities. They are occasionally seen over the 
chest wall and neck. Retroperitoneal lesions, frequently encountered in cases of human 
hemangiopericytoma, are rare in the dog. The tumors become more prevalent with advancing 
age. Ninety-five percent of the dogs with hemangiopericytomas presented to veterinarians are 6-
14 years of age. Radiographs do not demonstrate boney invasion. The blood supply to these 
neoplasms is usually adequate to maintain tissue viability, even in large tumor masses, but it is 
typically less than the blood supply of surrounding normal tissues. 
 
The histopathological appearance of canine hemangiopericytomas is like that of modified 
fibrosarcomas (1-3) and develops in a whorling cellular arrangement, frequently termed a 
"fingerprint" pattern. The malignant growths seem to originate from the vascular sheath (in 
humans, called pericytes of Zimmermann) around open or collapsed capillaries. Individual cells 
of hemangiopericytomas usually contain plump, ovoid nuclei, unlike the more flattened spindle 
cells of fibrosarcomas and other mesenchymal growths. 
 
Clinically, hemangiopericytomas behave in a locally invasive, nonmetastatic manner and 
generally do not respond well to any single routine therapy. Their recurrence rates after surgical 
excision have ranged from 25 to 60%. Tumors with a high mitotic index are more likely to recur 
(2). Available literature does not show that either irradiation or chemotherapy alone can 
effectively control hemangiopericytomas. 
 
The present study provides preliminary data on the effects of orthovoltage irradiation in 
combination with microwave-induced hyperthermia in spontaneous canine 
hemangiopericytomas. We chose the dog over the rodent as the animal model because 1) the 
tumor-to- patient size ratio is more comparable to that of humans, 2) it is extremely difficult to 
administer heat to rodent tumors without creating regional or systemic heating, whereas in the 
dog heat administration is relatively easily achieved, and 3) heating instruments of the size 
designed for humans may be used on dogs, whereas they are too large for use in rodents. We 
chose this particular tumor as a model because 1) it is spontaneously occurring and may 
therefore resemble human tumors more than induced or transplanted tumors, 2) it lacks systemic 
involvement, and 3) therapy is easily applied to lesions on extremities or the body wall. 
 
Problems arose in trying to evaluate quantitatively the effectiveness of the treatment. It was 
difficult to document accurately tumor volume before therapy because of irregular tumor shape 
and varying degrees of normal tissue infiltration. It was also virtually impossible to measure 
accurately tumor volume during therapy because of tissue reactions (e.g., ulceration, necrosis, 
inflammation, and varying surface characteristics). Therefore, to evaluate quantitatively the 
effectiveness of the treatment, we constructed and evaluated a rating scale to describe the clinical 
behavior of a locally invasive, nonmetastatic tumor undergoing therapy for control of local 
disease. The statistical methods used to evaluate the rating scale seem to be unique in 
comparative oncology: Using a relatively small sample size, we were able to predict with a high 
degree of confidence that 1) our findings were representative of the population as a whole, 
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2) tumor response following completion of therapy could be documented objectively, and, 3) our 
clinical observations were statistically significant. This paper uses these statistical methods to 




MATERIALS AND METHODS 
 
Animals.-- Eleven dogs with histopathologically confirmed hemangiopericytomas were procured 
through the PCOP and presented to the Small Animal Clinic, Purdue University, for pretreatment 
and post-treatment evaluations. The PCOP is a network of over 140 cooperating veterinarians 
from Lafayette and Indianapolis, Indiana and is dedicated to the compassionate use of pet 
animals with spontaneous neoplasia as models for human as well as veterinary cancer therapy. 
The dogs underwent treatment between July 1980 and February 1983. Laboratory profiles, 
including a complete hemogram, serum biochemical evaluation, urinalysis, and screening for 
parasites, were obtained prior to each dog's initial entry into the study. Radiographic evaluations 
of the thorax, abdomen, and primary lesions were conducted on all animals. The tumors 
underwent biopsy, and the animals were clinically staged and classified according to standards 
published by the World Health Organization (14). Dogs with local disease were entered into the 
study only if they were expected to survive 6 weeks or more. The dogs were maintained in their 
home environments between treatments and after courses of therapy were completed. Careful 
follow-up was conducted by direct examination. Final survival dates were verified by telephone 
contact. 
 
Therapy.-- Chemical restraint was induced following the administration of atropine sulfate (0.05 
mg/kg) given sc. Twenty minutes later a mixture of ketamine HCl (2.2 mg/kg) (Ketaset
®
, Bristol 
Laboratories Inc., Syracuse, N.Y.) and xylazine (1.1 mg/kg) (Rompun
®
; Haver-Lockhart, 
Shawnee, Kansas) was given iv by a bolus over 5 seconds. Repeat administration of the chemical 
restraint was occasionally required to maintain immobilization during prolonged therapy. 
Radiation was delivered at 7-day intervals by either a 200- or a 300-kVP orthovoltage X-ray 
therapy unit with a half-value layer of 1.1 mm Cu or 1.42 mm Cu, respectively. Fractions were 
delivered in increments of either 400-600 CGy with the 200-kVP unit or 800 CGy with the 300-
kVP unit. Immediately after X-ray therapy, the dogs were given local heat therapy with either an 
Elmed 2,450-MHz diathermy unit or a Burdick 2,450-MHz microwave generator. A 2-cm air gap 
was maintained between the surface of the microwave applicator and the tumor. Core body 
temperature was monitored periodically by rectal probes. Invasive needle-mounted thermistors 
or thermocouples, placed either directly into the tumor or into preplaced Teflon catheters, were 
used to monitor intratumoral and surrounding temperatures. Periodic monitoring in three to six 
intratumoral locations was conducted. Hyperthermia was administered for 20-30 minutes, and 
the animals were allowed to recover. One “course of treatment” was defined as seven weekly 
treatments or a portion thereof needed to induce CR of the tumor. CR was determined by clinical 
observation and confirmed by biopsy and histopathological examination of the tumor site. 
Response to therapy was evaluated immediately following completion of a course of treatment; 
additional evaluations were made 1 month and 3 months, 6 months, and then every 6 months 




Statistical methods and analysis.-- In this study survival was important and was evaluated; 
however, response to local therapy in this non-life-threatening tumor model had equal or greater 
importance. The goal of our analysis was to measure the animal’s intermediate response to 
therapy without waiting until death. We adopted a "scaled response" statistical analysis in which 
numerical scores were assigned to clinical status as follows: P = 2, R = 1, SD = 0, PR = +1, 
and CR = +2 (table 1). Each dog in the study was assigned a response score, according to this 
scale, from 2 to +2. Dogs demonstrating initial improvement and then R had their scores 
summed, thereby providing an overall performance score for that course of therapy (table 2). 
Such scores were not assigned until 30 days after a course of treatment was completed. 
 
 





The statistical evaluation of the scaled responses assumes that the variable is continuous between 
the integers and the spacing is truly equal. The key concept of the analysis is to calculate the 
95% confidence interval for either the mean response score, when more powerful parametric 
methods are used, or the median response score, when nonparametric methods are used. If the 
95% confidence limits overlap a response score of zero, then the therapy has no significant 
effect. If the 95% confidence intervals include a range of scores strictly greater than zero, then 
the therapy does have significant benefit in local palliation. Finally, if the 95% confidence 
intervals include a range of scores strictly less than zero, the therapy is significantly detrimental 










An adequate sample size must be assured to allow the extremes of the sample to be at least the 
95% confidence interval on the mean. A minimum of 6 dogs must be used in any such study for 
parametric evaluation (15). If nonparametric methods are used to establish a 95% confidence 
interval for the median, the extreme data points are excluded so the second and next-to-last data 
points would be used. If 7 dogs are evaluated by this method, the first and last data points in the 
array have to be used, thereby precluding the establishment of a 95% confidence interval. In this 
study there were 11 dogs. Ideally, at least 12 dogs might have been studied because then the third 
and the third-to-last point for the interval could have been used, thereby allowing elimination of 





In this study, a decision had to be made whether to use a parametric or a nonparametric analysis 
of the scaled responses. A parametric analysis was preferable to nonparametric procedures 
because its confidence and tolerance intervals are shorter. For parametric methods to be used, the 
population from which the scaled responses come must be approximately normal. Since the 
sample size is usually less than 50, the Shapiro-Wilk W-test should be used to test for normality 
(16-20). If the test for normality is accepted, the parametric procedures may be used on the 
scaled responses. Although the probability,  , of accepting the hypothesis when it is false may 
be large, the probability,  , of rejecting the hypothesis when it is true may be set at 0.01. A 
small    is suggested because the t-distribution is to be used to set a confidence interval on the 
population mean, and the  t  statistic is quite robust (i.e., allows nearly correct confidence 
intervals even when the population is not quite normal). If the population is not approximately 
normal, the data should be transformed and rechecked for normality (16-20). 
 
If the transformed data allow acceptance of a normal distribution, parametric data analysis may 
still be used and a confidence interval on the transformed population mean may be calculated. 
The lower and upper limits of this confidence interval are determined, and those limits are 
retransformed to the original scale. This final confidence interval is not determined by a “least-
squares” analysis (the most desirable method of calculating an estimate), but it is routinely used 
by applied statisticians. In this way, 95% confidence intervals for the mean response scores may 
be constructed for the subjects studied. If a suitable transformation cannot be found after several 
tries, a nonparametric median confidence interval may be constructed. This interval will be wider 
than a parametric mean confidence interval, but it is statistically sound. 
 
In addition to finding the confidence interval on the population mean, many investigators are 
interested in finding the percent of the population that will lie above the lowest observed 
response in the experimental group with a certain confidence. This statistic is called a one-sided 
tolerance limit. In a like manner for the confidence interval on the population mean, the 







An initial objective response rate of 91% was obtained in the 11 dogs studied (table 2). Nine 
animals demonstrated CR; one PR; and one SD. Of the 9 dogs in CR, five demonstrated R at 60-
340 days following CR (table 3), and three were available for a second course of therapy. Of the 
three dogs treated again, 100% demonstrated CR: One died in CR; two demonstrated R at 46 and 
61 days after therapy. Of these two relapsing dogs, one underwent euthanasia with persistent 
tumor 159 days later. The other received a third course of therapy and underwent CR, but it 
relapsed 422 days later and was eventually sacrificed. Of the eleven dogs, five either died free of 




All eleven cases showed therapeutic complications including ulceration of the tumor site, and 
most developed tumor necrosis with sloughing and eventual healing by second intention. Two 
dogs had distant metastases of the tumor. In one case, it was necessary to administer hydralazine 










Intratumoral temperatures of greater than 43 °C for 10 minutes were planned and achieved at 
least once in all dogs; however, the ease with which we obtained this goal was extremely 
variable among dogs and also among treatments for the same dog. We found it extremely 
difficult to heat tumors less than 3 cm
3
 to 43 °C without also heating the surrounding tissue to 
this cytotoxic temperature. Desired temperatures became increasingly difficult or impossible to 
achieve as tumors ulcerated, sloughed, and decreased in bulk during the courses of therapy. 
Homogeneous temperature distributions throughout the tumors were difficult to obtain. Heat was 
deposited most intensely under the center of the microwave applicator, so the heat source had to 
be moved from point to point over the tumor to obtain total tumor heating. Furthermore, since 
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microwave heating interfered with accurate thermometry, temperature monitoring was limited to 
brief, intermittent periods when the microwave generators were turned off. While heat was being 
applied, the invasive temperature probes were removed from the tumors. Microwave power was 
turned off every 3-5 minutes while the temperature probes were inserted and moved from site to 
site within and around the tumor. Approximately 10 seconds was needed at each of the three to 
six thermometry sites to obtain stable temperature readings; thus the last of six measured sites 
was not monitored until more than a minute of cooling time had occurred after cessation of 
microwave power. The tumors seemed to heat in a "stair-step" manner.  However, the increments 
of temperature rise in the early minutes of heating were often small, followed by an 
unpredictable major temperature elevation to greater than 50 °C. Table 4 summarizes the heat 
dose obtained during all treatments for each dog. 
 
 









a) The ordered response scores for the 11 animals were (0, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2). These 
scaled responses are denoted  yi  where i = 1, 2, ... , 11 and the sample size is n = 11. 
 
b) The Shapiro-Wilk W-test for normality yielded W = 0.793 (see "Appendix A") and was 
greater than the theoretical W (0.792) for  = 0.01. Hence the hypothesis that the data are 
normally distributed was accepted. 
 
c) The 95% confidence interval on the population mean,  , of the scaled response was 
calculated. It ranged from 0.84 to 1.71 (see "Appendix B"). Since the 95% confidence interval 
does not include the value zero, significant local palliation was caused by irradiation combined 
with hyperthermia. If use of  = 0.01 is considered too liberal, the weaker nonparametric 
procedure may be used satisfactorily. A 98.8% confidence interval may be established by use of 
the same array (0, l, l, 1, l, 1, l, 2, 2, 2, 2) and (15), on the basis of a sample size of 11, where the 
second and the second-to-last values are the extremes (i.e., l, 2). Although this example looks 
very good compared to our parametric evaluation, which gave a 95% confidence interval of 0.84-
1.71 assuming normality, this same result for the nonparametric confidence interval should be 
understood to occur for the array 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2. 
 
d) The parametric one-sided (upper) tolerance limit (see "Appendix C") indicated that we could 
be 90% confident that 89% of the population of dogs treated as we treated these dogs would have 
an objective clinical improvement (i.e., a scaled response greater than zero). If the one-sided 
tolerance limit were applied to the nonparametrically evaluated data, a sample size of 11 would 
allow 70% confidence that 89% of the population would be scored greater than zero (i.e., 





Of 11 dogs in this study, 10 showed improvement. This objective response rate of 91% suggests 
that irradiation when combined with hyperthermia is an effective method of treating 
hemangiopericytomas in dogs. Statistical methods show that this response is quantitatively 
significant. Not only did our small sample size meet criteria necessary to reflect the population as 
a whole, but the outcome also predicted with a 90% confidence that the observed responses were 
beneficial to 89% of the patients. This method of statistical analysis of scored clinical responses 
in small numbers of patients appears to solve a common problem in clinical research: It provides 
an objective method to evaluate critically data accumulated under conditions requiring clinical 
observations where precise measurements are difficult to obtain. 
 
Relapse in 5 cases may have resulted from inadequate X-radiation doses, since therapies were 
interrupted once CR was obtained (table 5). Biopsy samples taken from ulcerated margins at the 
time of CR revealed no residual microscopic foci of tumor; however, only a small portion of any 
tumor site could be sampled, and viable tumor cells were apparently left in situ where they 
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caused the tumor to relapse. A search of the literature from 1967 to the present reveals only poor 
response of fibrosarcomas to irradiation therapy (22, 23) and no success in treating canine 
hemangiopericytomas with irradiation therapy alone. In an attempt to correlate total radiation 
dose with the scored response, we constructed text-figure 1. The distribution suggested that a 
total radiation dose of at least 2,000 CGy provided the best response. Our present study suggests 











Local complications of irradiation-hyperthermia included thermal burns of both normal and 
neoplastic tissues when temperatures exceeded 45 °C. This result occurred at least once during 
the course of treatment in all 11 dogs. The burns and tumor necrosis resulted in open wounds and 
healing by second intention. Other complications included infection of the wounds, moderate 
anorexia, and fever, all of which were controlled by systemic antibiotic support. Long-term side 
effects included skin fibrosis, alopecia, and loss of pigmentation of the hair in the treatment field. 
Mild contracture of underlying tendons was also observed in 1 dog. These side effects were not 
life threatening. These were the only toxicities observed in the entire study.  
 
Temperature measurements actually may have been underestimated, since the measurement 
technique utilized intermittent hyperthermia, with temperature measurements recorded up to I 
minute after the microwave source was turned off. However, recent improvements in technology 
permit simultaneous heating and temperature monitoring so that burns need not develop. 
 
An attempt to correlate total thermal dose (min at > 43 °C), tumor size, and tumor location with 
the scored responses failed to reveal information that was helpful in predicting response to 
therapy. Text-figures 2-4 demonstrate these findings. As expected, most of the 
hemangiopericytomas occurred on the extremities, and there seemed to be no correlation of 
location with scored responses. Scored responses of +2 occurred in dogs receiving both low and 
high thermal doses as well as in dogs with both large and small tumors. Although extreme 
temperature elevations (> 50 °C) can cause thermal burns, and although it might be possible to 
cause tumor regression by protein coagulation, necrosis, and sloughing; our data did not suggest 
that such were the case. As many CR's were observed in dogs whose tumors never exceeded 50 
°C (dogs #3 and #11) as were observed in those that did reach such tissue-destructive 
temperatures. Additionally, we used hyperthermia alone in preliminary studies (Richardson RC, 
Voorhees WD III, Janas W, Babbs CF: Unpublished data) in an attempt to treat four 
hemangiopericytomas, one fibrosarcoma, one squamous cell carcinoma, and two transmissible 
venereal tumors in dogs. Temperatures greater than 50 °C were routinely obtained for at least 20 




























The unexpected metastasis of 2 hemangiopericytomas in this study might suggest that 
irradiation-hyperthermia stimulates metastatic events, as has been reported for osteogenic 
sarcomas (24). Our data, however, do not support this conclusion. One dog (#5) had received one 
course of irradiation-hyperthermia, resulting in PR.  Because tumor growth could not be 
controlled, the affected leg was amputated. At the time of amputation, no evidence of metastatic 
tumor was observed. Following amputation, axillary lymph node metastasis was observed and 
the dog underwent euthanasia. Necropsy revealed numerous pulmonary metastatic nodules. 
Although irradiation-hyperthermia may have stimulated a shedding of cells and metastasis, it is 
equally possible that they were present and undetected before treatment began, which would be 
problematic. The other case (#10) was not aggravated by experimental treatment; it had failed 
two courses of therapy, and this dog was sacrificed following repeated unsuccessful attempts to 
control the tumor surgically. Necropsy revealed pulmonary metastasis; however, careful review 
of radiographs made prior to any treatment demonstrated small pulmonary nodules that had not 
been observed initially. Metastasis had occurred in this dog before therapy had ever begun, as 
may well have been the case for dog #5. On the basis of observations of metastasis in cases such 
as these, until further studies have been conducted, this form of therapy should not be 
condemned. 
 
The positive response of this naturally occurring canine tumor to irradiation-hyperthermia is 
encouraging. Credence is provided to this response by statistical methods designed to evaluate a 
small sample size taken from the population as a whole. The benefits of such therapy should be 





Shapiro-Wilk W-test for normality:  
 




2) Calculate  b  by subtracting each low score from its corresponding high score in the array of 
scores [e.g., last high score (2) minus first low score (0), next-to-last high score (2) minus second 
low score (1), etc.] and by multiplying the result by the appropriate coefficient (16-20):  








4) Compare W with the theoretical W (0.792) using a = 0.01, which is indicated by the 
“percentage points” (16-20). 
 
5) Since the observed W (0.793) is greater than the theoretical W (0.792), accept the hypothesis 










y  = the sample mean of the scaled responses  
y = 1.273 
 








and  = population mean for which the confidence interval is estimated 
 










One-sided tolerance limit: To establish the lower limit of the tolerance interval ( y   Ks) as 0, set 
( y   Ks) = 0; knowing y  = 1.273 and 418.0s   from the data, K turned out to be  1.97. We 
utilized the method given in Odeh and Owen (25) to find a value of K that nearly matched the K 
= 1.97, where GAMMA = the confidence that the proportion is correct = 0.900, p = proportion of 
the population greater than the smallest scaled response (0) in the data = 0.900, and N = n = 11. 
Since the tabled K = 2.011 is greater than the calculated K = 1.97, we interpolated between 1.219 
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